Latest IR information
IR News
- 2026.01.29
- A New Approach to Multiple Sclerosis Treatment Using IV BCV Research Results from a Collaborative Study with the U.S. NIH Published in the Journal of Clinical Investigation
- 2026.01.16
- Notice Regarding Notice of the Large Volume Exercise of the 65th Stock Acquisition Rights (with Exercise Price Revision Clauses) Issued by way of Third-Party Allotment
- 2026.01.05
- Notice Regarding the Monthly Exercise Status of the 58th and 65th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued through Third-Party Allotment
- 2026.01.05
- Notice of Appointment of Corporate Officer Appointment of Minori Rosales as Corporate Officer and Head of Japan Development Division Strengthening the Global Expansion of IV BCV
- 2025.12.26
- Notice Regarding Notice of the Large Volume Exercise of the 65th Stock Acquisition Rights (with Exercise Price Revision Clauses) Issued by way of Third-Party Allotment